Continuous positive airway pressure versus high‐flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial
Respirology · 2024-01 · 29 (1) · 36-45
DOI: 10.1111/resp.14588 ↗At a glance
Randomisierte kontrollierte Studie in Respirology, published online on 2023-08-30. Written by Kazuma Nagata and 20 co-authors. Institution: Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan. Major MEDLINE topics: Continuous Positive Airway Pressure, Respiratory Insufficiency. Cited 16 times so far (Crossref); 27 references. Funded by: Philips Japan Limited.
Abstract (original language)
Background and Objective The relative effectiveness of initial non‐invasive respiratory strategies for acute respiratory failure using continuous positive airway pressure (CPAP) or high‐flow nasal cannula (HFNC) is unclear.
Methods
We conducted a multicenter, open‐label, parallel‐group randomized controlled trial to compare the efficacy of CPAP and HFNC on reducing the risk of meeting the prespecified criteria for intubation and improving clinical outcomes of acute hypoxemic respiratory failure. The primary endpoint was the time taken to meet the prespecified criteria for intubation within 28 days.
Results
Eighty‐five patients were randomly assigned to the CPAP or HFNC group. Eleven (28.9%) in the CPAP group and twenty (42.6%) in the HFNC group met the criteria for intubation within 28 days. Compared with HFNC, CPAP reduced the risk of meeting the intubation criteria (hazard ratio [HR], 0.327; 95% CI, 0.148–0.724; p = 0.006). There were no significant between‐group differences in the intubation rates, in‐hospital and 28‐day mortality rates, ventilator‐free days, duration of the need for respiratory support, or duration of hospitalization for respiratory illness. Pulmonary oxygenation was significantly better in the CPAP group, with significantly lower pH and higher partial pressure of carbon dioxide, but there were no differences in the respiratory rate between groups. CPAP and HFNC were associated with few possibly causal adverse events.
Conclusion
CPAP is more effective than HFNC at reducing the risk of meeting the intubation criteria in patients with acute hypoxemic respiratory failure.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
- Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
- Department of Pulmonary Medicine, Thoracic Center, St. Luke's International Hospital, Chuo City, Tokyo, Japan.
- Department of Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.
- Department of Pulmonary Medicine, Nagano Red Cross Hospital, Nagano, Nagano, Japan.
- Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Hiroshima, Japan.
ORCID profiles: Kazuma Nagata, Toru Kadowaki, Yasuhiro Kondoh
Funding
- Philips Japan Limited
Cite
APA
Nagata, K., Yokoyama, T., Tsugitomi, R., Nakashima, H., Kuraishi, H., Ohshimo, S., Mori, Y., Sakuraya, M., Kagami, R., Tanigawa, M., Tobino, K., Kamo, T., Kadowaki, T., Koga, Y., Ogata, Y., Nishimura, N., Kondoh, Y., Taniuchi, S., Shintani, A., …, & JaNP-Hi Study Investigators (2024). Continuous positive airway pressure versus high‐flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial. Respirology, 29(1), 36-45. https://doi.org/10.1111/resp.14588
Vancouver
Nagata K, Yokoyama T, Tsugitomi R, Nakashima H, Kuraishi H, Ohshimo S, et al. Continuous positive airway pressure versus high‐flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial. Respirology. 2024;29(1):36-45. doi:10.1111/resp.14588
BibTeX
@article{Nagata2024,
author = {Nagata, Kazuma and Yokoyama, Toshiki and Tsugitomi, Ryosuke and Nakashima, Harunori and Kuraishi, Hiroshi and Ohshimo, Shinichiro and Mori, Yoshihiro and Sakuraya, Masaaki and Kagami, Ryogo and Tanigawa, Motoaki and Tobino, Kazunori and Kamo, Tetsuro and Kadowaki, Toru and Koga, Yasutaka and Ogata, Yoshitaka and Nishimura, Naoki and Kondoh, Yasuhiro and Taniuchi, Satsuki and Shintani, Ayumi and Tomii, Keisuke and JaNP-Hi Study Investigators, JaNP-Hi Study Investigators},
title = {Continuous positive airway pressure versus high‐flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial},
journal = {Respirology},
year = {2024},
volume = {29},
number = {1},
pages = {36--45},
doi = {10.1111/resp.14588}
}
EUVIMED